JP Patent

JP7427703B2 — 放射線標識した前立腺特異的膜抗原（ＰＳＭＡ）阻害剤［１８Ｆ］ＤＣＦＰｙＬの改良合成

Assigned to Johns Hopkins University · Expires 2024-02-05 · 2y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7427703B2
Jurisdiction: JP
Classification: —
Expires: 2024-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Johns Hopkins University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.